Predictive biomarker analysis for clinical outcome in cancer patients using salivary cytokines

Predictive biomarker analysis for clinical outcome in cancer patients using salivary cytokines - Salivary cytokines analysis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000029444

Enrollment

110

Registered

2017-10-05

Start date

2017-10-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-small cell lung cancer, head and neck cancer, renal cell carcinoma, gastric cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: non-small cell lung cancer, renal cell carcinoma, head and neck tumor

Exclusion criteria

Exclusion criteria: sotomatitis

Design outcomes

Primary

Measure	Time frame
salivary cytokine panel and therapeutic response	—

Countries

Japan

Contacts

Public ContactTomonobu Koizumi

Shinshu University Comprehensive Cancer Therap, Medical School of Medicine

tomonobu@shinshu-u.ac.jp0263-37-2554

Outcome results